Baseline and interim [18F]FDG-PET/MRI to assess treatment response and survival in patients with M0 esophageal squamous cell carcinoma treated by curative-intent therapy

BACKGROUND: To investigate the value of [18F]FDG-PET/MRI in predicting treatment response and survival in patients with primary M0 esophageal squamous cell carcinoma. METHODS: Patients with esophageal squamous cell carcinoma received [18F]FDG-PET/MRI at baseline and during neoadjuvant or definitive...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Yin-Kai, Chang, Chun-Bi, Chang, Yu-Chuan, Chan, Sheng-Chieh, Chiu, Chien-Hung, Ng, Shu-Hang, Hsieh, Jason Chia-Hsun, Wang, Jen-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629192/
https://www.ncbi.nlm.nih.gov/pubmed/37932848
http://dx.doi.org/10.1186/s40644-023-00630-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629192/
https://www.ncbi.nlm.nih.gov/pubmed/37932848
http://dx.doi.org/10.1186/s40644-023-00630-2

Ejemplares similares